A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
Status:
Completed
Trial end date:
2008-06-20
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study designed to test the ability of investigational study drug
ARRY-371797 to reduce pain in a postoperative pain model (third molar extraction), and to
further evaluate the drug's safety. Approximately 250 subjects from the US will be enrolled
in this study.